The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| BG Medicine, Inc. | Com | 08861T107 | 181 | 441,072 | SH | SOLE | 0 | 441,072 | 0 | 0 | |
| Eleven Biotherapeutics, Inc. | Com | 286221106 | 4,596 | 1,907,008 | SH | SOLE | 0 | 1,907,008 | 0 | 0 | |
| Renewable Energy Group, Inc. | Com | 75972A301 | 268 | 32,331 | SH | SOLE | 0 | 32,331 | 0 | 0 | |
| Agios Pharmaceuticals, Inc. | Com | 00847X104 | 136,265 | 1,930,369 | SH | SOLE | 0 | 1,930,369 | 0 | 0 | |
| Seres Therapeutics, Inc. | Com | 81750R102 | 17,763 | 599,297 | SH | SOLE | 0 | 599,297 | 0 | 0 | |